This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Epilepsy Remove Patients Remove White Paper Related Topics
Chronic Pain Hash Consumption Seed-To-Sale Clinical Trials Treatment Access Sativa Recreational Tincture More Related Topics >
article thumbnail

What will unrestricted access to Medicinal Cannabis look like in Australia?

MGC Pharma

FEBRUARY 15, 2018

Physicians who want to prescribe Medicinal Cannabis are required to jump through countless regulatory hoops, as are patients seeking treatment. And though the benefits of Medicinal Cannabis are currently being utilised by only a small number of patients, the future’s certainly looking brighter for pain sufferers in Australia.

Access 100
Access Medicine Chronic Pain Research and Development 100
article thumbnail

Meritas Law Firms Worldwide Article: Global Cannabis Industry: The Essential Primer

Cannabis Law Report

OCTOBER 17, 2019

This white paper offers a primer to the complex and confusing global cannabis industry as it stands today. It’s big business,” says Jackim, noting that there are 200,000 patients in the state who hold cards allowing them to purchase cannabis for medical purposes. This is true even if the CBD comes from industrial hemp.

Law 40
Law Seed-To-Sale Hemp Recreational 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024